ArticleFrontiers in psychiatry2026
Association between neurodegenerative plasma biomarkers and geriatric depression in older adults with and without clinical dementia in Kinshasa, Democratic Republic of the Congo.
Article in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Previous Western studies have shown an association between neurodegenerative plasma biomarkers and geriatric depression. However, few studies have examined this relationship in sub-Saharan African countries. This article examines this association in older adults with or without clinical dementia in Kinshasa, Democratic Republic of Congo. Methods: This cross-sectional study included eighty-one people aged 65 years and older assessed for dementia using the Community Dementia Screening Instrument (CSID) and the Alzheimer's Disease Questionnaire. Depression and cognitive impairment were assessed using the Geriatric Depression Scale and the African Neuropsychological Battery (ANB), respectively. Plasma biomarkers measured included β-amyloid (Aβ) 40/42, phosphorylated tau 181 (p-tau), neurofilament light chain (NfL), glial fibrillar acid protein (GFAP), interleukins (IL-1β, IL-10), and tumor necrosis factor-α (TNF-α). Logistic regression models were used to estimate the likelihood that these biomarkers are associated with depression, adjusting for sex, age, and education level. Results: The mean age of the participants was 72.9 years. Of those suspected of suffering from Alzheimer's disease (AD), 80% had geriatric depression. High blood pressure was common in participants with suspected AD (60%). People with dementia had significantly lower cognitive scores on all ANB tests than those without dementia. GFAP and NfL were significantly associated with higher odds of geriatric depression, with odds ratios of 1.98 (1.17-3.67; p = 0.02) and 1.76 (1.06-3.20; p = 0.04), respectively. Other biomarkers were not associated with depression. Conclusion: This study suggests a potential role of nonspecific biomarkers of AD, neurodegeneration, and astrocytic glial activation in geriatric depression in older adults in sub-Saharan Africa.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.